1. 超敏C反应蛋白-白蛋白比值与急性缺血性卒中相关性肺炎 和早期临床结局的关系研究.
- Author
-
谢 冰, 刘 凡, and 李 娅
- Abstract
Objective To investigate the relationship between high-sensitivity C-reactive protein-albumin ratio(HCAR), acute ischemic stroke(AIS) associated pneumonia(SAP) and early clinical outcomes. Methods A total of 495 AIS who received treatment in the hospital from February 2021 to December 2022 patients with AIS were enrolled. All patients were divided into the SAP group and the non-SAP group according to whether SAP occurred during hospitalization. The patients were divided into four groups according to the quartile of HCAR level at admission[Q1 group(≤1. 3), Q2 group(1. 3-3. 7), Q3 group(3. 9-9. 2), Q4 group (≥9. 3)]. Baseline data at admission, data at discharge and 3-month follow-up data of all patients were collected. Univariate and multivariate logistic regression analysis were used to investigate the relationship between HCAR quartiles and SAP risk, 3-month adverse outcomes and 3-month all-cause mortality. Receiver-operating characteristic(ROC) curve was used to evaluate the predictive value of HCAR and other related indicators for SAP. Results SIP was diagnosed in 68(18. 6%) AIS patients during hospitalization, and the HCAR in the SAP group was significantly higher than that in the non-SAP group, the differences wase statistically significant( P <0. 001). In the unadjusted model, the incidence of SAP in Q2 group, Q3 group and Q4 group was significantly higher than that in the Q1 group(P <0. 05, Ptrend <0. 001). In the adjusted model, the incidence of SAP in Q2 group, Q3 group and Q4 group was also higher than that in Q1 group, and the incidence of SAP in Q3 group and Q4 group was significantly higher than that in Q1 group(P <0. 05, Ptrend <0. 001). ROC curve analysis showed that the AUC of HCAR was the largest, and the AUC of HCAR was significantly different from that of high-sensitivity C-reactive protein(hs-CRP) or albumin(Alb)(P <0. 05). There was no significant difference in AUC between HCAR and A2DS2 score(P >0. 05), but HCAR(sensitivity and specificity were 77. 17% and 73. 44%, respectively) had a more balanced sensitivity and specificity than A2DS2 score(sensitivity and specificity were 58. 72% and 83. 19%, respectively). HCAR at the Q4 level was significantly associated with adverse clinical outcomes(adjusted OR:Q4 vs. Q1 was 1. 98, Ptrend=0. 013). Patients with HCAR above Q3 had a higher risk of death within three months(adjusted OR:Q3 vs. Q1 was 2. 63, Q4 vs. Q1 was 3. 75, Ptrend=0. 001). Conclusion AIS patients with high HCAR levels at admission are more likely to develop SAP during hospitalization, and their early clinical outcomes are relatively worse. The incidence of adverse outcome and mortality rate at three months are higher. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF